Live Breaking News & Updates on Reneo pharmaceuticals

Stay updated with breaking news from Reneo pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update

IRVINE, Calif., March 28, 2024 -- Reneo Pharmaceuticals, Inc. , a pharmaceutical company historically focused on the development and commercialization of therapies for patients with rare genetic...

Danielle-spangler , Nasdaq , Exchange-commission , Reneo-pharmaceuticals , Reneo-pharmaceuticals-inc , Fourth-quarter , Full-year , Private-securities-litigation-reform-act , Ended-december , Markets ,

RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q4 2023

Reneo Pharmaceuticals (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith…

Reneo-pharmaceuticals , Place-earnings , News , Ggregator , Reaking-news , Uration , Edia ,

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors

SAN MATEO, Calif., March 25, 2024 -- Sagimet Biosciences Inc. , a clinical-stage biopharmaceutical company developing novel fatty acid synthase inhibitors designed to target dysfunctional...

Illinois , United-states , University-of-illinois , China , Canada , America , Asia-pacific , George-kemble , Dave-happel , Tim-walbert , Rick-rodgers , Sagimet-biosciences

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of ...

SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional

China , Illinois , United-states , Canada , University-of-illinois , America , Rick-rodgers , Paul-hoelscher , Dave-happel , Maria-yonkoski , Jinzi-wu , Asia-pacific

Pale Fire Capital SE Makes New Investment in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)

Pale Fire Capital SE purchased a new stake in shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 14,851 shares of the company’s stock, valued at approximately $113,000. A number of other institutional investors have also […]

United-states , America , Robertw-baird , York-mellon-corp , News-ratings-for-reneo-pharmaceuticals-daily , Barclays-plc , Wells-fargo-company , Reneo-pharmaceuticals-inc , Reneo-pharmaceuticals-company-profile , Dorsey-wright-associates , Reneo-pharmaceuticals-stock-performance

Pale Fire Capital SE Takes $113,000 Position in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)

Pale Fire Capital SE purchased a new stake in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Free Report) during the third quarter, HoldingsChannel.com reports. The firm purchased 14,851 shares of the company’s stock, valued at approximately $113,000. A number of other institutional investors have also recently modified their holdings of RPHM. Northern Trust Corp boosted its stake […]

United-states , America , Piper-sandler , William-blair , Renaissance-technologies , Reneo-pharmaceuticals-inc , Jefferies-financial-group , America-corp , Nasdaq , Reneo-pharmaceuticals-stock-performance , Reneo-pharmaceuticals , Quarter-for-reneo-pharmaceuticals

Reneo Pharmaceuticals to Cut 20% of Workforce in Second Round of Layoffs

By Ben Glickman Reneo Pharmaceuticals plans to cut more jobs, about 20% of its workforce, months after laying off the majority of its staff. The Irvine,...

Ben-glickman , Reneo-pharmaceuticals , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Labor-personnel , Corporate-industrial-news , Lay-offs-redundancies , Content-types , Factiva-filters , C-amp-ampe-industry-news-filter , Synd

Comparing Medicure (OTCMKTS:MCUJF) and vTv Therapeutics (NASDAQ:VTVT)

Medicure (OTCMKTS:MCUJF – Get Free Report) and vTv Therapeutics (NASDAQ:VTVT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Profitability This table compares Medicure and vTv Therapeutics’ […]

Canada , North-carolina , United-states , Novo-nordisk , Tv-therapeutics-inc , Medicure-inc , Macandrews-forbes-incorporated , Hangzhou-zhongmei-huadong-pharmaceutical-co-ltd , Reneo-pharmaceuticals-inc , Newsoara-biopharma-co-ltd , Get-free-report , Sodium-nitroprusside

Reneo Shares Dive 83% After Drug Fails Trial - Orange County Business Journal

The future of Irvine-based biopharmaceutical firm Reneo Pharmaceuticals Inc. (Nasdaq: RPHM) is in doubt after it disclosed last month that a clinical trial it oversaw failed to show the hoped-for results.

Greg-flescher , Nasdaq , Reneo-pharmaceuticals-inc , Reneo-pharmaceuticals , Chief-executive-greg-flescher , Business-journal ,

Cytokinetics, Burford Capital, Cipher Mining among premarket gainers' pack

Cytokinetics, Burford Capital, Cipher Mining among premarket gainers' pack
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Canada , Coherus-biosciences , Health-canada , Health-partners , Development-funding-agreement , Reneo-pharmaceuticals , Opthea-limited , First-wave-biopharma ,